Tirilazad mesylate improves survival of rat and human embryonic mesencephalic neurons in Vitro

Experimental Neurology

Volumn 147, Issue 2, 1997, Pages 498-502

  Othberg, Agneta ^a,b   Keep, Marcus ^a,c   Brundin, Patrik ^a   Lindvall, Olle ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c QUEEN S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; TIRILAZAD; U 83836F; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; DOPAMINERGIC NERVE CELL; DRUG EFFECT; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MESENCEPHALON; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

EID: 0031257754     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6594     Document Type: Article

References (22)

1. Braughler J. M., Hall E. D., Jacobsen E. J., McCall J. M., Means E. D. The 21-aminosteroids: Potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia. Drug Future. 14:1989;143-152.
2. Brundin P., Isacson O., Björklund A. Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res. 331:1985;251-259.
3. Fleischaker J. C., Peters G. R., Cathcart K. S., Steenwyk R. C. Evaluation of the pharmacokinetics and tolerability of Tirilazad mesylate, a 21-aminosteroid free radical scavenger: II. Multiple dose administration. J. Clin. Pharmacol. 33:1993;182-190.
4. Frodl E. M., Duan W-M., Sauer H., Kupsch A., Brundin P. Human embryonic dopamine neurons xenografted to the rat: effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and function. Brain Res. 647:1994;286-298.
5. Frodl E. M., Nakao N., Brundin P. Lazaroids improve the survival of cultured rat embryonic mesencephalic neurons. NeuroReport. 5:1994;2393-2396.
6. Grasbon-Frodl E. M., Nakao N., Brundin P. The lazaroid U-83836E improves the survival of rat embryonic mesencephalic tissue stored at 4°C and subsequently used for cultures or intracerebral transplantation. Brain Res. Bull. 39:1996;341-348.
7. Grasbon-Frodl E. M., Brundin P. Dopamine neuron death induced by congeners of nitrogen monoxide is prevented by the lazaroid U-83836E. Exp. Brain Res. 113:1997;138-143.
8. Grasbon-Frodl E. M., Andersson A., Brundin P. Lazaroid treatment prevents death of cultured rat embryonic mesencephalic neurons following glutathione depletion. J. Neurochem. 67:1996;1653-1660.
9. Jacobsen E. J., McCall J. M., Ayer D. E., Vandoornik F. J., Palmer J. R., Belonga K. L., Braugler J. M., Hall E. D., Houser D. J., Krook M. A., Runge T. A. Novel 21 aminosteroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma. J. Med. Chem. 33:1994;1145-1151.
10. Kawamoto J., Barrett J. Cryopreservation of primary neurons for tissue culture. Brain Res. 384:1986;84-93.
11. Kordower J. H., Freeman T. B., Snow B. J., Vingerhoets F. J. G., Mufson E. J., Sanberg P. R., Hauser R. A., Smith D. A., Nauert G. M., Pearl D. P., Olanow C. W. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of embryonic mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332:1995;1118-1124.
12. Kordower J. H., Rosenstein J. M., Collier T. J., Burke M. A., Chen E. R., Li J. M., Martel L., Levey A., Mufson E. J., Freeman T. B., Olanow C. W. Functional embryonic nigral grafts in a patient with Parkinson's disease, Chemoanatomic, ultrastructural and metabolic studies. J. Comp. Neurol. 370:1996;203-230.
13. Lindvall O. Neural transplantation in Parkinson's disease. Functional Neural Transplantation. 1994;Raven Press, New York. p. 103-137.
14. Nakao N., Frodl E. M., Duan W.-M., Widner H., Brundin P. Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc. Natl. Acad. Sci. USA. 91:1994;12408-12412.
15. Nakao N., Frodl E. M., Widner H., Carlsson E., Eggerding F. A., Epstein C., Brundin P. Over-expressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nature Med. 1:1995;226-231.
16. Olanow C. W. A radical hypothesis for neurodegeneration. Trends Neurosci. 16:1993;439-444.
17. Olanow C. W., Kordower J. H., Freeman T. B. Embryonic nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19:1996;102-109.
18. Othberg A., Odin P., Ballagi A., Åhgren A., Funa K., Lindvall O. Specific effects of platelet Y-derived growth factor (PDGF) on embryonic rat and human dopaminergic neurons in vitro. Exp. Brain Res. 105:1995;111-122.
19. Pakkenberg B., Müller A., Gundersen H. J. G., Mouritzen Dam A., Pakkenberg H. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. J. Neurol. Neurosurg. Psychiatr. 54:1991;30-33.
20. Sauer H., Brundin P. Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts. Rest. Neurol. Neurosci. 2:1991;123-135.
21. Smith S. L., Scherch H. M., Hall E. D. Protective effects of tirilazad mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrhage and lipid peroxidative neuronal injury. J. Neurosurg. 84:1995;229-233.
22. Stroke. 25:1994;418-423.